Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Braskem (BAK) Other Accumulated Expenses (2016 - 2025)

Braskem has reported Other Accumulated Expenses over the past 17 years, most recently at -$82.3 million for Q1 2025.

  • For Q1 2025, Other Accumulated Expenses changed N/A year-over-year to -$82.3 million; the TTM value through Mar 2025 reached -$82.3 million, changed N/A, while the annual FY2024 figure was $358.9 million, 19.3% down from the prior year.
  • Other Accumulated Expenses for Q1 2025 was -$82.3 million at Braskem, down from $358.9 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $444.8 million in Q4 2023 and troughed at -$82.3 million in Q1 2025.
  • A 5-year average of $115.0 million and a median of -$171078.4 in 2022 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: surged 260096.18% in 2023 and later dropped 19.3% in 2024.
  • Year by year, Other Accumulated Expenses stood at $193.9 million in 2021, then crashed by 100.09% to -$171078.4 in 2022, then surged by 260096.18% to $444.8 million in 2023, then dropped by 19.3% to $358.9 million in 2024, then tumbled by 122.92% to -$82.3 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for BAK at -$82.3 million in Q1 2025, $358.9 million in Q4 2024, and -$59.2 million in Q2 2024.